Fundraising Fox

Oncocyte

NASDAQ: IMDX

Irvine, US · California corporation

Biotech

Founders & leadership

JR
Joshua RiggsPresident and Chief Executive Officer and Director
AJ
Andrea JamesChief Financial Officer
JL
James LiuSenior Director, Controller & Principal Accounting Officer
DT
Douglas T RossExecutive
PS
Padmavathi SundarExecutive
RA
Ronald A AndrewsExecutive
ML
Mitchell LevineExecutive

Board

AD
Alfred D KingsleyBoard director
AA
Andrew ArnoBoard director
AL
Andrew LastBoard director
LS
Louis SilvermanBoard director
MG
Melinda GriffithBoard director

Reported raises · per SEC filings

Form D private placements

$83M disclosed across 9 rounds · 2015–2025

▶$21.7MraisedFeb 2025 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Louis SilvermanDirector
  • Andrew LastDirector
  • Joshua RiggsExecutive Officer, Director
  • Andrea JamesExecutive Officer
  • James LiuExecutive Officer
  • Andrew ArnoDirector
Offering amount
$21.7M
Amount sold
$21.7M
First sale
Feb 2025
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.2MraisedOct 2024 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew ArnoDirector
  • Joshua RiggsExecutive Officer, Director
  • Andrew LastDirector
  • Andrea JamesExecutive Officer
  • James LiuExecutive Officer
  • Louis SilvermanDirector
Offering amount
$10.2M
Amount sold
$10.2M
Sales commissions
$250K
Placement agents
Needham & Company, LLC
First sale
Oct 2024
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.8MraisedApr 2024 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joshua RiggsExecutive Officer, Director
  • James LiuExecutive Officer, Director
  • Louis SilvermanDirector
  • Andrew ArnoDirector
  • Alfred KingsleyDirector
  • Andrew LastDirector
Offering amount
$15.8M
Amount sold
$15.8M
Sales commissions
$250K
Placement agents
Needham & Company, LLC
First sale
Apr 2024
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedApr 2021 · 75 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Douglas T RossExecutive Officer
  • Andy ArnoDirector
  • Melinda GriffithDirector
  • Padmavathi SundarExecutive Officer
  • Jennifer Levin CarterDirector
  • Ronald A AndrewsExecutive Officer, Director
  • Mitchell LevineExecutive Officer
  • Cavan RedmondDirector
  • Alfred D KingsleyDirector
  • Andrew J LastDirector
Offering amount
$17.5M
Amount sold
$3M
First sale
Apr 2021
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedMar 2021 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Cavan RedmondDirector
  • Melinda GriffithDirector
  • Alfred D KingsleyDirector
  • Mitchell LevineExecutive Officer
  • Padmavathi SundarExecutive Officer
  • Douglas T RossExecutive Officer
  • Jennifer Levin CarterDirector
  • Ronald A AndrewsExecutive Officer, Director
  • Andrew J LastDirector
  • Andy ArnoDirector
Offering amount
$5M
Amount sold
$5M
First sale
Feb 2021
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedFeb 2020 · 29 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew ArnoDirector
  • Cavan RedmondDirector
  • Alfred KingsleyDirector
  • Aditya MohantyDirector
  • Melinda GriffithDirector
  • Andrew LastDirector
  • Mitch LevineExecutive Officer
  • Ronald AndrewsExecutive Officer, Director
  • Albert ParkerExecutive Officer
Offering amount
$11M
Amount sold
$5M
First sale
Jan 2020
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10.5MraisedSep 2016 · 9 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Russell SkibstedExecutive Officer
  • Don BaileyDirector
  • Cavan RedmondDirector
  • William AnnettExecutive Officer, Director
  • Andrew LastDirector
  • Aditya MohantyDirector
  • Alfred KingsleyDirector
  • Andrew ArnoDirector
Offering amount
$10.5M
Amount sold
$10.5M
Sales commissions
$511K
Placement agents
Cowen & Company, LLC
First sale
Aug 2016
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.3MraisedOct 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alfred D. KingsleyDirector
  • Cavan RedmondDirector
  • Kristine C. MechemExecutive Officer
  • Michael WestDirector
  • Robert W. PeabodyExecutive Officer, Director
  • Andrew ArnoDirector
  • William AnnettExecutive Officer, Director
  • Karen B. ChapmanExecutive Officer
  • Aditya MohantyDirector
Offering amount
$11.4M
Amount sold
$8.3M
Proceeds to insiders
$787.5K
First sale
Sep 2015
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Oncocyte Raises $29.1 Million to Develop, Commercialize Transplant Assays - Orange County Business Journalocbj.com · Feb 2025Oncocyte Secures $29.1Mln Funding Led By Bio-Rad To Advance Transplant Diagnostics, Stock Down | Nasdaqnasdaq.com · Feb 2025Oncocyte Enters $29.1M Securities Purchase Agreement | GenomeWebgenomeweb.com · Feb 2025Oncocyte raises $35M capital through equity offering (NASDAQ:OCX) | Seeking Alphaseekingalpha.com · Feb 2021

Frequently asked questions

How much funding has Oncocyte raised?
Oncocyte has disclosed $83M raised across 9 rounds.
Where is Oncocyte headquartered?
Oncocyte is headquartered in Irvine, US.